BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Allegaert K, Anker JN, Meibohm B, Phelps SJ, Mehrotra N, Tang L. Creatinine-Based Vancomycin Dosing Regimens in Neonates: There Is More to Consider Than the Variation in Drug Assay. Pharmacotherapy 2012;32:e174-5. [DOI: 10.1002/j.1875-9114.2012.01180.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Neuman G, Nulman I, Adeli K, Koren G, Colantonio DA, Helldén A. Implications of serum creatinine measurements on GFR estimation and vancomycin dosing in children. J Clin Pharmacol 2014;54:785-91. [PMID: 24596064 DOI: 10.1002/jcph.281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
2 Samardzic J, Allegaert K, Wilbaux M, Pfister M, van den Anker JN. Quantitative clinical pharmacology practice for optimal use of antibiotics during the neonatal period. Expert Opin Drug Metab Toxicol 2016;12:367-75. [PMID: 26817821 DOI: 10.1517/17425255.2016.1147559] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
3 Le J, Ngu B, Bradley JS, Murray W, Nguyen A, Nguyen L, Romanowski GL, Vo T, Capparelli EV. Vancomycin monitoring in children using bayesian estimation. Ther Drug Monit 2014;36:510-8. [PMID: 24452067 DOI: 10.1097/FTD.0000000000000039] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 4.1] [Reference Citation Analysis]
4 Samardzic J, Smits A, Spriet I, Soldatovic I, Atkinson A, Bajcetic M, Van Den Anker JN, Allegaert K. Different Vancomycin Immunoassays Contribute to the Variability in Vancomycin Trough Measurements in Neonates. Biomed Res Int 2016;2016:1974972. [PMID: 27635396 DOI: 10.1155/2016/1974972] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
5 Bhongsatiern J, Stockmann C, Roberts JK, Yu T, Korgenski KE, Spigarelli MG, Desai PB, Sherwin CM. Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target. Ther Drug Monit 2015;37:756-65. [PMID: 26562817 DOI: 10.1097/FTD.0000000000000216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]